Analyst
Contributor's Links: Graycell Advisors Prudent Biotech

Besides being an Analyst on both the Buyside and Sellside, the author has worked in Corporate Strategy and Finance roles for technology services companies and has now been publishing risk-adjusted, return-driven, quantitative model portfolios for many years at Graycell Advisors. More ... more

ALL CONTRIBUTIONS

Biotechs Feel The Bern
The market doesn't like uncertainty.
Read
4 Biotech Stocks In Neurology, As Biotechs March On
In a space of 2-months, biotechs have gone from recording yearly lows in early October, to recording 2019 highs.
Read
Healthcare & Biotechs Struggle, But Opportunity Ahead
Improving risk appetite is nudging markets higher, and biotechs will participate as well, although gains will have a ceiling.
Read
EC The Trade War Has An Upside
The trade friction is helpful if it nudges the Federal Reserve to adopt a more accommodative policy.
Read
Biotech Stocks Getting Ready To Explode
Biotech shares are up this year, as represented by the Nasdaq Biotechnology Index (IBB​), which is the industry benchmark, and the S&P Select Biotechnology Index (XBI), after a sharp decline in 2018. This is a welcome respite for biotech investors.
Read
A Biotech Friendly Event In An Unfriendly Healthcare Market
May thus far has been mostly a downward ride with an occasional rise, proving to be a mere bunny bump, as indexes have eroded persistently on the lack of a trade resolution with China, an outcome that was considered to be almost in the bag.
Read

Comments

Latest Comments
Suicide Is Painless
2 years ago

A quick market pulse!

Thanks for the key highlights of the day.

In this article: DB, GM, TSN, WFC, GOOG, SNAP
1 to 1 of 1 comments

STOCKS I FOLLOW

BXUB Barclays Bank PLC
BXUC Barclays Bank PLC
DIA SPDR Dow Jones Industrial Average
EPS WisdomTree Earnings 500 Fund
IBB iShares Nasdaq Biotechnology Index Fund
IVV iShares S&P 500 Index Fund
IWM iShares Russell 2000 Index Fund
LLSP Direxion Daily S&P 500 Bull 1.25X ETF
QQQ PowerShares QQQ Trust Series 1
RSP Rydex S&P Equal Weight ETF
RWL RevenueShares Large Cap ETF
RYARX Rydex Series Fds Inverse S&P 500 Strategy Fund
SDS ProShares UltraShort S&P500
SFLAF iPath Long Extended S&P 500 TR ETN
SH ProShares Short S&P500
SPLX UBS ETRACS M Reset 2xLvg S&P 500 TR ETN
SPUU Direxion Daily S&P 500 Bull 2X ETF
SPXE ProShares S&P 500 ex-Energy
SPXL Direxion Daily S&P500 Bull 3X ETF
SPXN ProShares S&P 500 ex-Financials
SPXS Direxion Daily S&P500 Bear 3X ETF
SPXT ProShares S&P 500 ex-Technology
SPXU ProShares Trust
SPXV ProShares S&P 500 ex-Health Care
SPY SPDR S&P 500
Load More

TWEETS

PERSONAL BLOG

Latest Posts
A Federal Reserve Jolt
Stocks have been highly volatile in October as rising concerns about the direction of interest rates have taken center stage and diminished the risk appetite of investors.
Biotech: The Gates Begin To Open
We believe 2018 will be a positive year for biotechnology and we will witness record new all-time highs
Biotech Bonanza: Biotech Stocks To Continue Higher In 2018
During 2017, the Biotechnology sector delivered a solid performance. However, the sector still remains ~15% below its all-time highs. Biotech stocks should continue performing strongly in 2018, and investors must consider a portfolio exposure.
When The Bulls Growl & The Bears Moo! Stock Market Outlook 2018
The year 2017 will be remembered as the year when the Bulls Growled and the Bears Mooed.
Biotech Bonanza: Breaking New Ground!
Biotechnology has started off the year on a strong note, and finally breached a level that presented stiff resistance in the past.

Work Experience

Education

Publications

Prudent Biotech
Tarun Chandra, CFA
Graycell Advisors
Tarun Chandra, CFA